Insider · CIK 0001980648

Lee Chan Henry

Reports to the SEC for 1 company · BASEL

sec.gov

Transactions

Companies

Filings

CIK

0001980648

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-30	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−1,115 sh	$375.00	−$418K	0
2026-08-11	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+812 sh	$194.47	+$158K	812
2026-08-11	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+1,058 sh	$213.32	+$226K	1,870
2026-08-11	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+796 sh	$159.03	+$127K	2,666
2026-08-11	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−2,666 sh	$360.00	−$960K	0
2026-08-11	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−10.6K sh	—	—	0
2026-08-11	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−13.8K sh	—	—	57,369
2026-08-11	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−10.3K sh	—	—	88,582
2026-07-30	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−1,044 sh	$323.69	−$338K	0
2026-07-22	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+514 sh	$194.47	+$100K	514
2026-07-22	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+665 sh	$213.32	+$142K	1,179
2026-07-22	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+490 sh	$159.03	+$77.9K	1,669
2026-07-22	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−1,669 sh	$325.00	−$542K	0
2026-07-22	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−6,682 sh	—	—	10,556
2026-07-22	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−8,645 sh	—	—	71,123
2026-07-22	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−6,370 sh	—	—	98,930
2026-07-08	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+202 sh	$194.47	+$39.3K	202
2026-07-08	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+266 sh	$213.32	+$56.7K	468
2026-07-08	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+196 sh	$159.03	+$31.2K	664
2026-07-08	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−664 sh	$302.46	−$201K	0
2026-07-08	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−2,626 sh	—	—	17,238
2026-07-08	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−3,458 sh	—	—	79,768
2026-07-08	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−2,548 sh	—	—	105,300
2026-06-16	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−590 sh	$265.98	−$157K	0
2026-06-11	ONCBeOne Medicines Ltd.A Award	SVP, General Counsel	AAward	+45.1K sh	—	—	346,554
2026-06-11	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−428 sh	$257.63	−$110K	0
2026-06-11	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)A Award	SVP, General Counsel	AAward	+87.3K sh	—	—	87,308
2026-06-08	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−711 sh	$270.24	−$192K	160
2026-06-08	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−160 sh	$271.26	−$43.4K	0
2026-05-13	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+101 sh	$194.47	+$19.6K	101
2026-05-13	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+133 sh	$213.32	+$28.4K	234
2026-05-13	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+98 sh	$159.03	+$15.6K	332
2026-05-13	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−332 sh	$310.72	−$103K	0
2026-05-13	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−1,313 sh	—	—	19,864
2026-05-13	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−1,729 sh	—	—	83,226
2026-05-13	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−1,274 sh	—	—	107,848
2026-04-08	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+101 sh	$194.47	+$19.6K	101
2026-04-08	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+133 sh	$213.32	+$28.4K	234
2026-04-08	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+98 sh	$159.03	+$15.6K	332
2026-04-08	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−332 sh	$311.59	−$103K	0
2026-04-08	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−1,313 sh	—	—	21,177
2026-04-08	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−1,729 sh	—	—	84,955
2026-04-08	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−1,274 sh	—	—	109,122
2026-03-11	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+110 sh	$194.47	+$21.4K	110
2026-03-11	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+133 sh	$213.32	+$28.4K	243
2026-03-11	ONCBeOne Medicines Ltd.M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	+98 sh	$159.03	+$15.6K	341
2026-03-11	ONCBeOne Medicines Ltd.S Sale	SVP, General Counsel	SSale	−341 sh	$300.00	−$102K	0
2026-03-11	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−1,430 sh	—	—	22,490
2026-03-11	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−1,729 sh	—	—	86,684
2026-03-11	ONCBeOne Medicines Ltd. · Share Option (Right to Buy)M Exercise/Conversion	SVP, General Counsel	MExercise/Conversion	−1,274 sh	—	—	110,396

Recent filings

Accepted (ET)
Oct 24
Lee Chan Henry0001980648-26-000027
SEC(opens sec.gov)
Aug 134
Lee Chan Henry0001980648-26-000024
SEC(opens sec.gov)
Aug 34
Lee Chan Henry0001980648-26-000021
SEC(opens sec.gov)
Jul 244
Lee Chan Henry0001980648-26-000019
SEC(opens sec.gov)
Jul 104
Lee Chan Henry0001980648-26-000017
SEC(opens sec.gov)

Companies

BeOne Medicines Ltd.SVP, General CounselONC

Address

C/O BEONE MEDICINES I GMBH AESCHENGRABEN 27, 21ST FLOOR

BASEL, 4051